- BioMarin to obtain pediatric business from
Medicis.
BioMarin Pharmaceutical, Inc. (Novato, CA) announced that it has signed definitive agreements with Medicis Pharmaceutical Corporation to obtain its Pediatric Business as defined in the transaction documents. The transaction includes: Orapred, a patent-protected drug to treat asthma in children; two additional proprietary formulations of Orapred in development; and a United ......
- Stradling Lawyer Wins for Generics; Appeal Pending
HEADNOTE Doctors' Blood Boils Over CalOptima HMO; Blue Shield Honors Hospitals for Cardiac Care HEALTHCARE A patent fight led by an Orange County law firm could add up to a windfall for a generic drug maker. U.S. District Judge Robert Timlin last month granted a summary judgment in favor of ......
- Reliant acquires Abbott's
antiarrhythmic.
Reliant Pharmaceuticals, LLC (Liberty Corner, NJ), a privately held, rapidly growing pharmaceutical company that markets branded, patent-protected pharmaceutical products in the United States, announced that it has signed a definitive agreement to acquire the United States rights to the Rythmol (propafenone HCl) product family from Abbott Laboratories. Dr. Ernest Mario, ......
- Reliant acquires Abbott's
antiarrhythmic.
Reliant Pharmaceuticals, LLC (Liberty Corner, NJ), a privately held, rapidly growing pharmaceutical company that markets branded, patent-protected pharmaceutical products in the United States, announced that it has signed a definitive agreement to acquire the United States rights to the Rythmol (propafenone HCl) product family from Abbott Laboratories. Dr. Ernest Mario, ......
- Inamed Loose End: Allergan Acquires Juv?derm's Creator
Allergan Inc. has gone to France to tie up a loose end from its $3.2 billion spring buy of Santa Barbara's Inamed Corp.
- United States: Garnier Garners brickbats
He's a Frenchman based in the US, but the battle over his pay claim may become a defining moment in the gathering struggle over executive compensation. Jean-Pierre Garnier, chief executive of pharmaceutical giant GlaxoSmithKline, had asked for an improved pay package, saying his current arrangements were out of line with ......
- Where has quality gone?
In late 1999, Abbott Labortories, a leading U.S. health care company, reached an agreement with the U.S. Food and Drug Administration (FDA) to pay $100 million for failure to comply with the Good Manufacturing Practices (GMP) regulations. The payment marked the largest amount ever paid by an FDA-regulated company for ......